KRAS and intestinal cancer: A recent study revealed that Kras-driven mouse models of pancreatic and intestinal cancers were less responsive to depletion of serine and glycine, reflecting the ability of activated Kras to increase the expression of enzymes that are part of the serine biosynthesis pathway.11 However, how Kras activates the SGOC pathway remains unclear.